Combination therapy incorporating 3 new agents shows promise as treatment for aggressive lymphoma

New research from Roswell Park Cancer Institute (RPCI) shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse… Source link